
|Videos|June 19, 2021
Assessing IOL options for cataract patients
Author(s)OT Staff Reports, Alex Delaney-Gesing
In recognition of Cataract Awareness Month, Fasika Woreta, MD, MPH, discusses IOL options for cataract patients.
Advertisement
Fasika Woreta, MD, MPH, of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, discusses the determining factors and indicators to consider when treating cataract patients with IOLs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
DAYBREAK: Tarcocimab, tabirafusp-ted noninferior to aflibercept in wet AMD
2
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
3
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
4
Remigromig noninferior to ranibizumab in phase 2b/3 BRUNELLO DME trial
5













